Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Shenkman Capital Management
Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Shenkman Capital Management
from 13F filings
Historical chart of Shenkman Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Shenkman Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $5.9B | 5.2M | 1141.73 |
| 2024-09-30 | $1.3B | 1.1M | 1136.56 |
| 2024-06-30 | $3.5B | 2.7M | 1292.68 |
| 2024-03-31 | $3.2B | 2.7M | 1171.16 |
| 2023-12-31 | $3.6B | 3.5M | 1020.58 |
| 2023-09-30 | $4.2B | 3.7M | 1122.46 |
More positions owned by Shenkman Capital Management
View all positions for Shenkman Capital Management
Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1
View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1